search
Back to results

Aniseikonia in Epiretinal Membrane Patients

Primary Purpose

Epiretinal Membrane

Status
Unknown status
Phase
Not Applicable
Locations
Denmark
Study Type
Interventional
Intervention
Cataract guideline
Sponsored by
Glostrup University Hospital, Copenhagen
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Epiretinal Membrane

Eligibility Criteria

40 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Epiretinal membrane Phakic on both eyes

Exclusion Criteria:

  • no previous eye surgeries
  • refractive status +/- 2 seq

Sites / Locations

  • Eye department, Nordre ringvej 56Recruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Cataract guideline

Standard refraction

Arm Description

In this patients we follow cataract guideline and correct the patients ametropia during the cataract surgery

The patients gets an IOL ensuring his preoperatively refraction

Outcomes

Primary Outcome Measures

Aniseikonia
Measure amount of aniseikonia by measuring aniseikonia with both computer program aniseikonia inspector and the New Aniseikonia test

Secondary Outcome Measures

Full Information

First Posted
August 31, 2018
Last Updated
September 5, 2018
Sponsor
Glostrup University Hospital, Copenhagen
search

1. Study Identification

Unique Protocol Identification Number
NCT03661593
Brief Title
Aniseikonia in Epiretinal Membrane Patients
Official Title
Aniseikonia in Epiretinal Membranes
Study Type
Interventional

2. Study Status

Record Verification Date
September 2018
Overall Recruitment Status
Unknown status
Study Start Date
November 1, 2017 (Actual)
Primary Completion Date
January 2019 (Anticipated)
Study Completion Date
November 2019 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Glostrup University Hospital, Copenhagen

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Examination of aniseikonia in epiretinal membranes patients before and after surgery
Detailed Description
Phakic patients woth epiretinal membranes are examined for aniseikonia and refractive status before and after surgery. Follow up is one year.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Epiretinal Membrane

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
InvestigatorOutcomes Assessor
Masking Description
Masking done by a third person following computer randomization
Allocation
Randomized
Enrollment
25 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Cataract guideline
Arm Type
Experimental
Arm Description
In this patients we follow cataract guideline and correct the patients ametropia during the cataract surgery
Arm Title
Standard refraction
Arm Type
No Intervention
Arm Description
The patients gets an IOL ensuring his preoperatively refraction
Intervention Type
Other
Intervention Name(s)
Cataract guideline
Intervention Description
The patients gets an IOL according to cataract guideline correcting the ametropia
Primary Outcome Measure Information:
Title
Aniseikonia
Description
Measure amount of aniseikonia by measuring aniseikonia with both computer program aniseikonia inspector and the New Aniseikonia test
Time Frame
1 year

10. Eligibility

Sex
All
Minimum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Epiretinal membrane Phakic on both eyes Exclusion Criteria: no previous eye surgeries refractive status +/- 2 seq
Facility Information:
Facility Name
Eye department, Nordre ringvej 56
City
Copenhagen
State/Province
Glostrup
ZIP/Postal Code
2600
Country
Denmark
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Therese Krarup, MD
Phone
+45 38633963
Email
theresekrarup@gmail.com

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
No planing on sharing

Learn more about this trial

Aniseikonia in Epiretinal Membrane Patients

We'll reach out to this number within 24 hrs